Foley Partner Courtenay Brinckerhoff was quoted in an article that appeared in Pharmacogenomics Reporter on July 31, 2011 titled “Appeals Court Decides Isolated DNA Patentable, Myriad’s Analytical Method Claims Not.” Brinckerhoff discusses the Court of Appeals for the Federal Circuit’s ruling that isolated gene sequences are patentable, stating that the decision could have a far-reaching impact on other patents and personalized medicine type claims. She adds that practitioners and patent holders may want to review pending and granted claims to determine if they are affected by recent decisions regarding gene patent eligibility.
People
Related News
July 2, 2025
In the News
John Strom and Peter Tomasi Quoted on Shift in Environmental Policy
Foley & Lardner LLP attorneys John Strom and Peter Tomasi commented on changes to federal environmental rules in the Utility Dive article, "Federal agencies, including FERC and DOE, revoke environmental review rules."
June 30, 2025
In the News
Lynn Gandhi Assesses Midyear Takeaways from Major State and Local Tax Cases
Foley & Lardner LLP partner Lynn Gandhi is featured by Law360 for her takeaways on major state and local tax cases in the article, "Top State & Local Tax Cases Of 2025: Midyear Report."
June 27, 2025
In the News
Donald Schroeder Highlights FMCS Importance Amid Service's Uncertain Future
Foley & Lardner LLP partner Donald Schroeder described the Federal Mediation and Conciliation Services' (FMCS) importance in the Law360 article, "As Feds' Bargaining Mediator Ails, New Services Emerge."